Back to Journals » Drug Design, Development and Therapy » Volume 9

A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan

Total article views   HTML views PDF downloads Totals
14,005 Dovepress* 11,245+ 1,952 13,197
PubMed Central* 2,760 490 3,250
Totals 14,005 2,442 16,447
*Since 31 March 2015
+Since July 2016

View citations on PubMed Central and Google Scholar